Basic Research Services for Brain Tumors

Brain tumors, like most other malignant tumors, are mostly resistant to various treatment modalities such as traditional radiotherapy and chemotherapy due to the diverse genotypic and phenotypic variations. Moreover, the existence of the blood-brain barrier prevents chemotherapeutic drugs for intracranial tumors from reaching the tumor tissue, objectively limiting the efficacy of most chemotherapeutic drugs. In addition, some brain tumors (e.g., glioma) have their biological characteristics, which infiltrate into the surrounding normal brain tissues at the beginning, making surgical operations almost impossible to completely remove the tumor. Therefore, it is more important to search for new therapeutic strategies for brain tumors from the basic research level.

Services we provide for basic brain tumor research

Alfa Cytology' services include brain tumor stem cell analysis, circulating tumor cell assays, rare cell analysis, cell microarrays, and quantitative DNA analysis of brain tumor cells. At the tissue level, we offer tissue microarrays as well as organoid and organ microarray services. Of course, we also have extensive experience in brain tumor-specific gene analysis, genomics, spatial transcriptomics, metabolomics, proteomics, imaging omics, genetic analysis, and gene microarrays. We have a wide range of sequencing methods, including whole genome sequencing, whole exome sequencing, targeted sequencing, single-cell sequencing, methylation sequencing, single-cell nuclear RNA sequencing, and nanopore sequencing for brain tumors, which can meet your different research needs. Please contact our staff to submit your request.